1 – 10 of 12
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2014
-
Mark
A novel panel of biomarkers predicts radioresistance in patients with squamous cell carcinoma of the head and neck.
(
- Contribution to journal › Article
- 2006
-
Mark
p53 mutation and cyclin D1 amplification correlate with cisplatin sensitivity in xenografted human squamous cell carcinomas from head and neck.
(
- Contribution to journal › Article
- 2004
-
Mark
Genetic and expression profiles of squamous cell carcinoma of the head and neck correlate with cisplatin sensitivity and resistance in cell lines and patients
(
- Contribution to journal › Article
-
Mark
Overexpression of cyclin D1 correlates with sensitivity to cisplatin in squamous cell carcinoma cell lines of the head and neck
(
- Contribution to journal › Article
-
Mark
Amplification of the cyclin D1 gene is associated with tumour subsite, DNA non-diploidy and high S-phase fraction in squamous cell carcinoma of the head and neck
(
- Contribution to journal › Article
- 2003
-
Mark
The gene ratios c-MYC : Cyclin-dependent kinase (CDK)N2A and CCND1 : CDKN2A correlate with poor prognosis in squamous cell carcinoma of the head and neck
(
- Contribution to journal › Article
- 2002
-
Mark
Chromosomal translocations involving 11q13 contribute to cyclin D1 overexpression in squamous cell carcinoma of the head and neck
(
- Contribution to journal › Article
-
Mark
Karyotypic heterogeneity and clonal evolution in squamous cell carcinomas of the head and neck.
(
- Contribution to journal › Article
- 2001
-
Mark
Cyclin D1 overexpression versus response to induction chemotherapy in squamous cell carcinoma of the head and neck--preliminary report
(
- Contribution to journal › Article
- 1999
-
Mark
Abnormal cell cycle regulation in malignancy
(
- Contribution to journal › Scientific review